Fennec Pharmaceuticals (FENC) Net Cash Flow Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn | 208.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 208.44% |
| Sep 30, 2025 | 218.58% |
| Jun 30, 2025 | 51.17% |
| Mar 31, 2025 | -110.44% |
| Dec 31, 2024 | -1,673.10% |
| Sep 30, 2024 | -6.84% |
| Jun 30, 2024 | -136.89% |
| Mar 31, 2024 | 804.22% |
| Dec 31, 2023 | 114.55% |
| Sep 30, 2023 | -117.25% |
| Jun 30, 2023 | -2.63% |
| Mar 31, 2023 | -89.51% |
| Dec 31, 2022 | -84.79% |
| Sep 30, 2022 | 601.59% |
| Jun 30, 2022 | 24.45% |
| Mar 31, 2022 | 20.93% |
| Dec 31, 2021 | -14.64% |
| Sep 30, 2021 | 46.83% |
| Jun 30, 2021 | -115.35% |
| Mar 31, 2021 | 4.16% |
| Dec 31, 2020 | -77.48% |
| Sep 30, 2020 | -148.90% |
| Jun 30, 2020 | 1,146.01% |
| Mar 31, 2020 | -47.02% |
| Dec 31, 2019 | 8.78% |
| Sep 30, 2019 | -100.27% |
| Jun 30, 2019 | -155.42% |
| Mar 31, 2019 | -65.48% |
| Dec 31, 2018 | -109.39% |
| Sep 30, 2018 | -105.15% |
| Jun 30, 2018 | -115.46% |
| Mar 31, 2018 | -128.30% |
| Dec 31, 2017 | 3,139.61% |
| Sep 30, 2017 | 0.00% |
| Jun 30, 2017 | 53.90% |
| Mar 31, 2017 | -70.03% |
| Dec 31, 2016 | -44.10% |
| Sep 30, 2016 | -11.48% |
| Jun 30, 2016 | 7,416.13% |
| Mar 31, 2016 | -1.53% |
| Dec 31, 2015 | -124.74% |
| Sep 30, 2015 | -15.64% |
| Jun 30, 2015 | 80.80% |
| Mar 31, 2015 | -20.31% |
| Dec 31, 2014 | 52.36% |
| Sep 30, 2014 | 10.02% |
| Jun 30, 2014 | 63.67% |
| Mar 31, 2014 | 20.15% |
| Dec 31, 2013 | 301.97% |
| Sep 30, 2013 | 35.40% |
| Jun 30, 2013 | 21.54% |
| Mar 31, 2013 | 29.58% |
| Dec 31, 2012 | 27.38% |
| Sep 30, 2012 | -14.15% |
| Jun 30, 2012 | -163.94% |
| Mar 31, 2012 | 44.85% |
| Dec 31, 2011 | -17.10% |
| Sep 30, 2011 | -15.64% |
| Jun 30, 2011 | -73.96% |